Scenario.press - libera espressione Scenario.press - libera espressione
Risultati di ricerca
Mostra tutti i risultati
  • Iscriviti
    Accedi
    Iscriviti
    Cerca
    Modalità Notturna

Cerca

Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie

  • Notizie
  • ESPLORA
  • Pagine
  • Gruppi
  • Eventi
  • Blogs
  • Marketplace
  • Finanziamento
  • Offerte
  • Lavori
  • Corsi
  • Film
  • Sviluppatori
  • Articoli
  • Blogs
  • Utenti
  • Pagine
  • Gruppi
  • Eventi
  • guptatanmayuds1308 Aggiunto blog Altre informazioni
    2025-06-25 07:08:13 -
    Adeno-Associated Virus (AAV) Gene Therapy Market Outlook: Technological Advancements & Forecast (2024–2032) | UnivDatos
    According to a new report by Univdatos, Adeno-Associated Virus Gene Therapy Market, is expected to reach USD 70 Billion in 2032 by growing at a CAGR of 39%. Adeno-Associated Virus (AAV) gene therapy has emerged as a groundbreaking approach in the treatment of various genetic and acquired disorders. In the United States, the field has seen remarkable advancements, with numerous clinical trials...
    0 Commenti 0 Condivisioni 780 Visualizzazioni
    Effettua l'accesso per mettere mi piace, condividere e commentare!
  • vikasdada Aggiunto blog Altre informazioni
    2025-08-19 10:22:13 -
    Global CRISPR Gene-Editing Market Overview, Growth Analysis, Trends and Forecast By 2032
    "Regional Overview of Executive Summary CRISPR Gene-Editing Market by Size and Share The global CRISPR gene-editing market size was valued at USD 1.83 billion in 2024 and is expected to reach USD 14.74 billion by 2032, at a CAGR of 29.8% during the forecast period A consistent market research report like CRISPR Gene-Editing Market report extends reach to the...
    0 Commenti 0 Condivisioni 120 Visualizzazioni
    Effettua l'accesso per mettere mi piace, condividere e commentare!
© 2025 Scenario.press - libera espressione Italiano
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About us Terms & Conditions Privacy Business Model Donazioni Contattaci Elenco